Maxivate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 5 EU WC, 2 KDMF, 11 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

143 FDF Dossiers, 79 FDA Orange Book, 7 Europe, 3 Canada, 24 Australia, 9 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Actylis, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 1 Kerry, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

26 Topical, 13 Film Formers & Plasticizers, 8 Emulsifying Agents, 7 Solubilizers, 6 Parenteral, 6 Thickeners and Stabilizers, 5 Coating Systems & Additives, 5 Lubricants & Glidants, 5 Fillers, Diluents & Binders, 4 Taste Masking, 3 Controlled & Modified Release, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients